Yuzo Terakawa

Diagnostic Accuracy of ¹¹C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy

Yuzo Terakawa, Naohiro Tsuyuguchi, Yoshiyasu Iwai et al. · Journal of Nuclear Medicine · 2008 · 420 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 265 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas

Hideyuki Arita, Manabu Kinoshita, Atsushi Kawaguchi et al. · Scientific Reports · 2018 · 101 citations · Full text

Medicine, Oncology, Radiology +17

Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network

Ryohei Fukuma, Takufumi Yanagisawa, Manabu Kinoshita et al. · Scientific Reports · 2019 · 75 citations · Full text

Medicine, Oncology, Radiology +17

Diagnosis of Brain Tumors Using Amino Acid Transport PET Imaging with ¹⁸F-fluciclovine: A Comparative Study with L-methyl-¹¹C-methionine PET Imaging.

Naohiro Tsuyuguchi, Yuzo Terakawa, Takehiro Uda et al. · PubMed · 2017 · 63 citations · Full text

Medicine, Nuclear Medicine, Radiology +15